1 / 15

CANOLFAN GOGLEDD CYMRU AR GYFER YMCHWIL GOFAL CYCHWYNNOL

PRIFYSGOL BANGOR / BANGOR UNIVERSITY. Developing and testing new models of follow-up care in cancer Dr Richard Neal Clinical Senior Lecturer in General Practice North Wales Centre for Primary Care Research r.neal@bangor.ac.uk. CANOLFAN GOGLEDD CYMRU AR GYFER YMCHWIL GOFAL CYCHWYNNOL

harsha
Télécharger la présentation

CANOLFAN GOGLEDD CYMRU AR GYFER YMCHWIL GOFAL CYCHWYNNOL

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PRIFYSGOL BANGOR / BANGOR UNIVERSITY Developing and testing new models of follow-up care in cancerDr Richard NealClinical Senior Lecturer in General PracticeNorth Wales Centre for Primary Care Researchr.neal@bangor.ac.uk CANOLFAN GOGLEDD CYMRU AR GYFER YMCHWIL GOFAL CYCHWYNNOL NORTH WALES CENTRE FOR PRIMARY CARE RESEARCH

  2. Overview PRIFYSGOL BANGOR / BANGOR UNIVERSITY • Why follow-up in cancer? • Differing models for follow-up and the evidence for them • Some theory about contemporary follow-up • Using two examples to consider the development and evaluation of the design of future trials

  3. Why follow-up in cancer? PRIFYSGOL BANGOR / BANGOR UNIVERSITY • Detect recurrence (patients’ main concern) • Assess response and side-effects of treatment • Assess disease progression and further treatment planning • Preparing for palliative and terminal care • Assessment and treatment of psychosocial issues • Information provision • Ongoing management of co-morbidity • Co-ordination of care • Patient preference and reassurance • Continuity of care from treating doctor • Carer support • Clinical trials

  4. ‘Traditional’ hospital follow-up PRIFYSGOL BANGOR / BANGOR UNIVERSITY • Conventional hospital based follow-up places a considerable burden on hospital outpatient clinics • Is of debatable value for many cancers in terms of prompt diagnosis of recurrence and improved survival • Patients may find it reassuring • Patients may find it anxiety raising • Patients may find it a waste of time

  5. Who provides follow-up, and how? PRIFYSGOL BANGOR / BANGOR UNIVERSITY • Specialists • Medical / clinical oncologists • Surgeons • Physicians • GPs • Specialist nurses (nurse-led models) • Models • Traditional • Phone • Patient initiated • ….or a combination of these

  6. Huge variation in follow-up needs PRIFYSGOL BANGOR / BANGOR UNIVERSITY Patient: • By cancer • By stage • By treatment modality • By prognosis • By co-morbidity • By needs • By preference .....not a one size fits all

  7. PRIFYSGOL BANGOR / BANGOR UNIVERSITY

  8. PRIFYSGOL BANGOR / BANGOR UNIVERSITY A framework for holistic assessment of risks and needs

  9. Designing trials PRIFYSGOL BANGOR / BANGOR UNIVERSITY • Which patients? • Which interventions? • Biomarkers • Imaging • Clinical examination • Psycho-educational • Setting / clinician / mode • Which outcomes? • Patient safety • Detection of recurrence • Quality of Life • Satisfaction

  10. Developing interventions PRIFYSGOL BANGOR / BANGOR UNIVERSITY For lung and prostate cancers we have undertaken: • Guideline review • Systematic review • Case-note analysis • Database analysis • Qualitative study …….and developed / developing trial interventions

  11. Developing interventions PRIFYSGOL BANGOR / BANGOR UNIVERSITY For lung cancer: Primary care • Continues to see patients frequently after diagnosis • Knows these patients well • Is good at managing co-morbidity • Is good at smoking cessation • Is good at co-ordination and liaison Primary care is less good at • Specialist lung cancer knowledge • Understanding what is happening in secondary care

  12. Developing interventions PRIFYSGOL BANGOR / BANGOR UNIVERSITY For prostate cancer: • Need for robust primary research to inform future evidence-based models of follow-up care • Deficiencies in the system between primary and secondary care • Some patients falling between primary and secondary care and getting lost to follow-up • Identified steps needed to breakdown the barriers to make primary care follow-up happen • High levels of unmet needs (especially psychosocial, sexual, incontinence)

  13. A randomized controlled trial of a nurse-led psycho-educational intervention delivered in primary care to prostate cancer survivors (PROSPECTIV) PRIFYSGOL BANGOR / BANGOR UNIVERSITY • Funding: Prostate Cancer Charity, PI: Eila Watson, Oxford Brookes (with Bangor, Edinburgh, Oxford, Cambridge) • Cluster randomization (150 practices) • Identification of men suitable for discharge to primary care from participating practices • Screen to identify patients with problems (urinary, sexual, bowel, hormonal, anxiety / depression) (n=350) • Allocation to nurse led psycho-educational intervention or usual care • Follow up: 1, 6, 12 months • Main outcome: prostate cancer related quality of life

  14. Potential Macmillan funding for BCUHB / north Wales PRIFYSGOL BANGOR / BANGOR UNIVERSITY Interventions: • An ‘end of active treatment MDT’ held for prostate cancer patients held, for care planning, with levels of intervention stratified with risk of adverse events • An automated IT system linking primary and secondary for routine aspects (PSA) • Clinical Nurse Specialists as change agents to train primary care practitioners in the delivery of high quality patient-centred follow-up care

  15. Discussion / questions PRIFYSGOL BANGOR / BANGOR UNIVERSITY Dr Richard Neal North Wales Centre for Primary Care Research r.neal@bangor.ac.uk

More Related